Get notified when NCNO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsnCino accelerates buybacks with $200M term loan, cuts R&D staff 92 as growth slows to 10.6%
Filed May 27, 2026 · Period ending April 30, 2026 · Compared to 10-Q May 28, 2025 · ~2 min read
Key Changes
-
high
Company raised $200M term loan and launched $100M accelerated share repurchase, delivering 5.5M shares upfront at $14.98; Q1 repurchases totaled $110.5M vs $40.6M prior year, nearly tripling capital returns despite revenue growth decelerating from 12.5% to 10.6%.
MD&A: Capital Allocation verify on EDGAR → -
high
R&D headcount cut 92 employees (vs 52-person increase prior year from acquisitions), driving $4.5M expense reduction; company redirected $0.4M toward AI technology investments, signaling strategic pivot even as overall R&D spending contracts.
MD&A: Operating Expenses verify on EDGAR → -
high
Net income more than doubled to $13.6M from $5.6M; operating margin improved 1,420 bps as gross margin expanded 330 bps, driven by revenue growth and cost discipline (R&D fell from 23.1% to 18.1% of revenue, G&A from 15.0% to 10.8%).
MD&A: Results of Operations verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade NCNO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 28, 2026 · How we verify